20306543

Source:http://linkedlifedata.com/resource/pubmed/id/20306543

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023473, umls-concept:C0030705, umls-concept:C0178602, umls-concept:C0231174, umls-concept:C0871261, umls-concept:C0935989, umls-concept:C1522577, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	5
pubmed:dateCreated	2010-4-28
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7610369
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1096-8652
pubmed:author	pubmed-author:AlimenaGiulianaG, pubmed-author:BrecciaMassimoM, pubmed-author:CannellaLauraL, pubmed-author:Del FabroVittorioV, pubmed-author:Di RaimondoFrancescoF, pubmed-author:LatagliataRobertoR, pubmed-author:StagnoFabioF, pubmed-author:VigneriPaoloP
pubmed:issnType	Electronic
pubmed:volume	85
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	375-7
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20306543-Adult, pubmed-meshheading:20306543-Aged, pubmed-meshheading:20306543-Aged, 80 and over, pubmed-meshheading:20306543-Antineoplastic Agents, pubmed-meshheading:20306543-Cytogenetic Analysis, pubmed-meshheading:20306543-Dose-Response Relationship, Drug, pubmed-meshheading:20306543-Drug Resistance, Neoplasm, pubmed-meshheading:20306543-Female, pubmed-meshheading:20306543-Follow-Up Studies, pubmed-meshheading:20306543-Humans, pubmed-meshheading:20306543-Kaplan-Meier Estimate, pubmed-meshheading:20306543-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:20306543-Male, pubmed-meshheading:20306543-Middle Aged, pubmed-meshheading:20306543-Piperazines, pubmed-meshheading:20306543-Pyrimidines, pubmed-meshheading:20306543-Remission Induction, pubmed-meshheading:20306543-Young Adult
pubmed:year	2010
pubmed:articleTitle	Imatinib dose escalation in 74 failure or suboptimal response chronic myeloid leukaemia patients at 3-year follow-up.
pubmed:publicationType	Letter, Multicenter Study